Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New herbal remedy for liver diseases improves liver function and quality of life

July 8, 1998

Belgian scientists on the way to developing a therapeutic vaccine for HCV?

July 8, 1998

Novel flavonoid derivative SU-840 with potent gastroprotective and ulcer-healing effects

July 7, 1998

Anti-H. pylori compounds prepared at Fujisawa

July 3, 1998

First 10-day treatment for H. pylori infection approved by FDA

July 2, 1998

Centocor receives complete review letter for infliximab

July 2, 1998

Chugai begins clinical testing of prokinetic agent

July 2, 1998

FDA, Janssen advise of Propulsid warning label changes

July 1, 1998

Regulatory approval sought for lamivudine in U.S. for treatment of hepatitis B

June 30, 1998

FDA says Salix ulcerative colitis Rx approvable

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.